Primer Dismenore Tedavisinde Kullanılan Destekleyici Tıbbi Bitkiler Ve Mikro Besinler

Osayande AS, Mehulic S. Diagnosis and initial management of dysmenorrhea. American family physician, 2014; 89:341-346. doi: 10.1196/annals.1429.007

Ferries-Rowe E, Corey E, Archer JS. Primary dysmenorrhea: diagnosis and therapy. Ob- stetrics & Gynecology, 2020; 136:1047-1058. doi: 10.1097/AOG.0000000000004096.

Ghodsi, Z, Asltoghiri M. The effect of fennel on pain quality, symptoms, and menstrual duration in primary dysmenorrhea. Journal of pediatric and adolescent gynecology, 2014; 27: 283-286. doi: 10.1016/j.jpag.2013.12.003.

Ju H, Jones M, Mishra G. The prevalence and risk factors of dysmenorrhea. Epidemiolog- ic rewiews, 2014; 36:104-113. doi: 10.1093/epirev/mxt009

Harada T. Dysmenorrhea and endometriosis in young women. Yonago acta medica, 2013; 56:81.

Chen CX, Draucker CB, Carpenter JS. What women say about their dysmenorrhea: A qualitative thematic analysis. BMC women’s health, 2018; 18:1-8. doi.org/10.1186/ s12905-018-0538-8

Sharghi M, Mansurkhani SM, Larky DA, Kooti W, Niksefat M, Firoozbakht M, Jouybari

L. An update and systematic review on the treatment of primary dysmenorrhea. JBRA assisted reproduction, 2019; 23:51. doi: 10.5935/1518-0557.20180083

Dawood MY. Primary dysmenorrhea: advances in pathogenesis and management. Ob- stetrics & Gynecology, 2006; 108:428-441. doi: 10.1097/01.AOG.0000230214.26638.0c.

Ryan SA. The treatment of dysmenorrhea. Pediatric Clinics, 2017; 64:331-342. doi: 10.1016/j.pcl.2016.11.004

Morrow C, Naumburg EH. Dysmenorrhea. Primary care: Clinics in office practice, 2009; 36:19-32.doi: 10.1016/j.pop.2008.10.004

Iacovides S, Avidon I, Baker FC. What we know about primary dysmenorrhea today: a crit- ical review. Human reproduction update, 2015; 21:762-778. doi: 10.1093/humupd/dmv039

Sultan C, Gaspari L, Paris F. Adolescent dysmenorrhea. Pediatric and adolescent gynecol- ogy,2012; 22:171-180. doi: 10.1159/000331775

Proctor M, Farquhar C. Diagnosis and management of dysmenorrhoea. Bmj,2006; 332:1134-1138. doi: 10.1136/bmj.332.7550.1134

Chantler I, Mitchelln D, Fuller, A. Actigraphy quantifies reduced voluntary physical ac- tivity in women with primary dysmenorrhea. The Journal of Pain,2009; 10:38-46. doi: 10.1016/j.jpain.2008.07.002.

Gagua T, Tkeshelashvili B, Gagua D, Mchedlishvili N. Assessment of anxiety and depres- sion in adolescents with primary dysmenorrhea: a case-control study. Journal of pediatric and adolescent gynecology, 2013; 26:350-354. doi: 10.1016/j.jpag.2013.06.018.

Chan WY, Fuchs F, Powell AM. Effects of naproxen sodium on menstrual prostaglandins and primary dysmenorrhea. Obstetrics and gynecology, 1983; 61:285-291.

Alvin PE, Litt IF. Current status of the etiology and management of dysmenorrhea in adolescence. Pediatrics, 1982; 70:516-525.

Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and devel- opment. The American journal of clinical nutrition, 1991; 54:438-463. doi: 10.1093/ ajcn/54.3.438

Rees MC. 8 Heavy, painful periods. Baillière’s clinical obstetrics and gynaecology, 1989;

3:341-356. doi.org/10.1016/S0950-3552(89)80026-4

Liedman R, Skillern L, James I, Mcleod A, Grant L, Åkerlund M. Validation of a test model of induced dysmenorrhea. Acta obstetricia et gynecologica Scandinavica, 2006; 85:451-457. doi: 10.1080/00016340500432432

Hori Y. Diagnostic laparoscopy guidelines. Surgical endoscopy, 2008; 22:1353-1383. doi:10.1007/s00464-008-9759-5

Durain D. Primary dysmenorrhea: assessment and management update. Journal of mid- wifery & women’s health, 2004; 49:520-528. doi: 10.1016/j.jmwh.2004.08.013

Coco AS. Primary dysmenorrhea. American family physician, 1999; 60:489.

Zhang WY, Li Wan Po A. Efficacy of minor analgesics in primary dysmenorrhoea: a systematic review. BJOG: An International Journal of Obstetrics & Gynaecology, 1998; 105:780-789.doi: 10.1111/j.1471-0528.1998.tb10210.x

Allen LM, Lam, AC. Premenstrual syndrome and dysmenorrhea in adolescents. Adolescent medicine: state of the art reviews, 2012; 23:139-163. doi: 10.1196/annals.1429.007

Marjoribanks J, Ayeleke RO, Farquhar C, Proctor M. Nonsteroidal anti-inflamma- tory drugs for dysmenorrhoea. Cochrane database of systematic reviews,2015. doi: 10.1002/14651858.CD001751.pub3

Lefebvre G, Pinsonneault O, Antao V, Black A, Burnett M, Feldman K, Robert M. Pri- mary dysmenorrhea consensus guideline. J Obstet Gynaecol Can, 2005; 27:1117-46. doi: 10.1016/s1701-2163(16)30395-4.

Wong CL, Farquhar C, Roberts H, Proctor M. Oral contraceptive pill as treatment for primary dysmenorrhoea. Cochrane database of systematic reviews,2009. doi: 10.1002/14651858.CD002120.pub3.

Wiegratz I, Thaler CJ. Hormonal contraception-what kind, when, and for whom?.

Deutsches Ärzteblatt International, 2011; 108:495. doi: 10.3238/arztebl.2011.0495

Chan WY, Dawood MY. Prostaglandin levels in menstrual fluid of nondysmenorrheic and of dysmenorrheic subjects with and without oral contraceptive or ibuprofen therapy. Advances in prostaglandin and thromboxane research, 1980 8:1443-1447.

Chan WY, Dawood MY, Fuchs F. Prostaglandins in primary dysmenorrhea: Compar- ison of prophylactic and nonprophylactic treatment with ibuprofen and use of oral contraceptives. The American journal of medicine, 1981; 70:535-541.doi: 10.1016/0002- 9343(81)90576-3

Ekström P, Åkerlund M, Forslıng M, Kındahl H, Laudanskı T, Mrugacz G. Stimulation of vasopressin release in women with primary dysmenorrhoea and after oral contraceptive treatment effect on uterine contractility. BJOG: An International Journal of Obstetrics & Gynaecology, 1992; 99:680-684. doi.org/10.1111/j.1471-0528.1992.tb13855.x

Goldzieher JW, Moses LE, Averkin E, Scheel C, Taber BZ. A placebo-controlled dou- ble-blind crossover investigation of the side effects attributed to oral contraceptives. Fer- tility and sterility, 1971;22:609-623.

French L. Dysmenorrhea. American family physician, 2005; 71. (2):285-291

Johnson NP, Farquhar CM, Crossley S, Yu Y, Van Peperstraten AM, Sprecher M, Suckling

J. A double-blind randomised controlled trial of laparoscopic uterine nerve ablation for women with chronic pelvic pain. BJOG: An International Journal of Obstetrics & Gynae- cology, 2004; 111: 950-959. doi: 10.1111/j.1471-0528.2004.00233.x

Barnard ND, Scialli AR, Hurlock D, Bertron P. Diet and sex-hormone binding globulin, dysmenorrhea, and premenstrual symptoms. Obstetrics & Gynecology, 2000; 95:245-250. doi: 10.1016/s0029-7844(99)00525-6.

Rakhshaee Z. Effect of three yoga poses (cobra, cat and fish poses) in women with pri- mary dysmenorrhea: a randomized clinical trial. Journal of pediatric and adolescent gy- necology, 2011; 24:192-196. doi: 10.1016/j.jpag.2011.01.059.

Abbaspour Z, Rostami M, Najjar SH.The effect of exercise on primary dysmenorrhea.

Journal of Research in Health sciences, 2006; 6:26-31.

Golomb LM, Solidum AA, Warren MP. Primary dysmenorrhea and physical activity. Medicine and science in sports and exercise, 1998; 30:906-909. doi: 10.1097/00005768- 199806000-00020

Furniss LD. Nonsteroidal anti-inflammatory agents in the treatment of primary dysmen- orrhea. Clinical Pharmacy, 1982;1:327-333.

Bokaie M, Farajkhoda T, Enjezab B, Khoshbin A, Mojgan KZ. Oral fennel (Foenicu- lum vulgare) drop effect on primary dysmenorrhea: effectiveness of herbal drug. Iranian journal of nursing and midwifery research,2013; 18:128.

Zeraati F, Shobeiri F, Nazari M, Araghchian M, Bekhradi R. Comparative evaluation of the efficacy of herbal drugs (fennelin and vitagnus) and mefenamic acid in the treat- ment of primary dysmenorrhea. Iranian journal of nursing and midwifery research, 2014; 19:581.

Omidvar S, Esmailzadeh S, Baradaran M, Basirat Z. Effect of fennel on pain intensity in dysmenorrhoea: A placebo-controlled trial. Ayu, 2012; 33:311. doi: 10.4103/0974- 8520.105259.

Ghodsi Z, Asltoghiri M. The effect of fennel on pain quality, symptoms, and menstrual duration in primary dysmenorrhea. Journal of pediatric and adolescent gynecology, 2014; 27:283-286. doi: 10.1016/j.jpag.2013.12.003.

Aksoy AN, Gözükara I, Kucur SK. Evaluation of the efficacy of Fructus agni casti in women with severe primary dysmenorrhea: A prospective comparative D oppler study. Journal of Obstetrics and Gynaecology Research, 2014 40:779-784. doi: 10.1111/jog.12221.

Shirvani MA, Motahari-Tabari N, Alipour A. The effect of mefenamic acid and ginger on pain relief in primary dysmenorrhea: a randomized clinical trial. Archives of gynecology and obstetrics, 2015; 291:1277-1281. doi: 10.1007/s00404-014-3548-2.

Rahnama P, Montazeri A, Huseini HF, Kianbakht S, Naseri M. Effect of Zingiber of- ficinale R. rhizomes (ginger) on pain relief in primary dysmenorrhea: a placebo ran- domized trial. BMC complementary and alternative medicine, 2012;12:1-7. d o i : 10.1186/1472-6882-12-92.

Jenabi E. The effect of ginger for relieving of primary dysmenorrhoea. J Pak Med Assoc, 2013; 63:8-10.

Modarres M, Ali M, Oshrieh Z, Mehran A. Comparison of the effect of Mefenamic Acid and Matricaria Camomilla Capsules on primary dysmenorrhea. Journal of Babol Univer- sity of Medical Sciences, 2011; 13:50-58.

Mirabi P, Dolatian M, Mojab F, Majd HA. Effects of valerian on the severity and systemic manifestations of dysmenorrhea. International Journal of Gynecology & Obstetrics, 2011; 115:285-288. doi: 10.1016/j.ijgo.2011.06.022.

Heshmati A, Dolatian M, Mojab F, Nikkhah S, Mahmoodi, Z. The effect of peppermint (Mentha piperita) capsules on the severity of primary dysmenorrhea. Journal of Herbal Medicine, 2016; 6:137-141.doi: 10.1016/J.HERMED.2016.05.001

Masoumi SZ, Asl HR, Poorolajal J, Panah MH, Oliaei SR. Evaluation of mint efficacy regarding dysmenorrhea in comparison with mefenamic acid: A double blinded ran- domized crossover study. Iranian journal of nursing and midwifery research, 2016;21:363. doi: 10.4103/1735-9066.185574

Jenabi E, Fereidoony B. Effect of Achillea millefolium on relief of primary dysmenorrhea: a double-blind randomized clinical trial. Journal of pediatric and adolescent gynecology, 2015; 28:402-404. doi: 10.1016/j.jpag.2014.12.008

Younesy S, Amiraliakbari S, Esmaeili S, Alavimajd H, Nouraei S. Effects of fenugreek seed on the severity and systemic symptoms of dysmenorrhea. Journal of reproduction & infertility, 2014;15:41.

Jaafarpour M, Hatefi M, Khani A, Khajavikhan J. Comparative effect of cinnamon and Ibuprofen for treatment of primary dysmenorrhea: a randomized double-blind clinical trial. Journal of clinical and diagnostic research: JCDR, 2015; 9: QC04-07. doi: 10.7860/ JCDR/2015/12084.5783

Jahangirifar M, Taebi M, Dolatian M. The effect of Cinnamon on primary dysmenor- rhea: A randomized, double-blind clinical trial. Complementary therapies in clinical prac- tice, 2018; 33:56-60. doi: 10.1016/j.ctcp.2018.08.001.

Jaafarpour M, Hatefi M, Najafi F, Khajavikhan J, Khani A. The effect of cinnamon on menstrual bleeding and systemic symptoms with primary dysmenorrhea. Iranian Red Crescent Medical Journal, 2015;17. doi: 10.5812/ircmj.17(4)2015.27032

Abadian K, Keshavarz Z, Mojab F, Majd HA, Abbasi NM. Comparison the effect of mefenamic acid and Teucrium polium on the severity and systemic symptoms of dys- menorrhea. Complementary therapies in clinical practice, 2016;22:12-15. doi: 10.1016/j. ctcp.2015.09.003.

Abadian K, Keshavarz Z, Mojab F, Bromand N. The biological effects of Teucrium poli- um on the severity of primary dysmenorrhea. Journal of Applied Biotechnology Reports, 2016;3:453-456.

Heidarifar R, Mehran N, Heidari A, Koohbor M, Mansourabad MK. Effect of Dill (Anethum graveolens) on the severity of primary dysmenorrhea in compared with me- fenamic acid: A randomized, double-blind trial. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences, 2014; 19:326.

Mirabi P, Namdari M, Alamolhoda S, Mojab F. The effect of Melissa officinalis extract on the severity of primary dysmenorrha. Iranian journal of pharmaceutical research: IJPR, 2017; 16:171.

Mirabi P, Alamolhoda SH, Yazdkhasti M, Mojab F. The effects of lemon balm on men- strual bleeding and the systemic manifestation of dysmenorrhea. Iranian Journal of Pharmaceutical Research: IJPR, 2018; 17:214.

Bernath J, Nemeth E, Kattaa A, Hethelyi E. Morphological and chemical evaluation of fennel (Foeniculum vulgare Mill.) populations of different origin. Journal of essential oil research,1996; 8:247-253. doi.org/10.1080/10412905.1996.9700610

He W, Huang B. A review of chemistry and bioactivities of a medicinal spice: Foenicu- lum vulgare. Journal of Medicinal Plants Research, 2011; 5:3595-3600.

Deligeoroglou E. Dysmenorrhea. Annals of the New York Academy of Sciences, 2000;

900:237-244. doi: 10.1111/j.1749-6632.2000.tb06235.

Chan WY. Prostaglandins and nonsteroidal antiinflammatory drugs in dysmenorrhea. Annual review of pharmacology and toxicology, 1983;23:131-149. doi.org/10.1146/an- nurev.pa.23.04018.001023

Ostad SN, Soodi M, Shariffzadeh M, Khorshidi N, Marzban H. The effect of fennel essential oil on uterine contraction as a model for dysmenorrhea, pharmacology and toxicology study. Journal of ethnopharmacology, 2001; 76:299-304. doi: 10.1016/s0378- 8741(01)00249-5.

Mahboubi M. Foeniculum vulgare as valuable plant in management of women’s health.

Journal of menopausal medicine, 2019;25:1-14. doi: 10.6118/jmm.2019.25.1.1

Liu J, Burdette JE, Xu H, Gu C, Van Breemen RB, Bhat KP, Bolton JL. Evaluation of es- trogenic activity of plant extracts for the potential treatment of menopausal symptoms. Journal of agricultural and food chemistry, 2001; 49:2472-2479. doi: 10.1021/jf0014157.

van Die MD, Burger HG, Teede HJ, Bone KM. Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials. Planta medica, 2013; 79:562- 575. doi: 10.1055/s-0032-1327831.

Christie S, Walker AF. Vitex agnus-castus L.: A review of its traditional and modern ther- apeutic use; Current use from a survey of practitioners. Eur J Herbal Med, 1997; 3:29-45.

Jarry H, Leonhardt S, Gorkow CH, Wuttke W.In vitro prolactin but not LH and FSH release is inhibited by compounds in extracts of Agnus castus: direct evidence for a dopaminergic principle by the dopamine receptor assay. Experimental and Clinical Endocri- nology & Diabetes, 1994;102:448-454. doi: 10.1055/s-0029-1211317.

Sliutz G, Speiser P, Schultz AM, Spona J, Zeillinger R.Agnus castus extracts inhibit pro- lactin secretion of rat pituitary cells. Hormone and metabolic research, 1993;25:253-255. doi: 10.1055/s-2007-1002090

Röhrl J, Werz O, Ammendola A, Künstle G. Vitex agnus-castus dry extract BNO 1095 (Agnucaston®) inhibits uterine hyper-contractions and inflammation in experimen- tal models for primary dysmenorrhea. Clinical Phytoscience, 2017;2:1-12. doi:10.1186/ s40816-016-0034-3

Malhotra S, Singh AP. Medicinal properties of ginger (Zingiber officinale Rosc.) 2003. doi:10.1201/9781315187853-23

Pour HA, Norouzzade R, Heidari MR, Ogut S, Yaman H, Gokce S. Therapeutic proper- ties of Zingiber officinale roscoe: a review. European Journal of Medicinal Plants, 2014; 4:1431. doi:10.9734/EJMP/2014/11138

Kashefi F, Khajehei M, Alavinia M, Golmakani E, Asili, J. Effect of Ginger (Zingiber officinale) on heavy menstrual bleeding: A placebo-controlled, randomized clinical trial. Phytotherapy research, 2015;29:114-119. doi: 10.1002/ptr.5235.

Ali BH, Blunden G, Tanira MO, Nemmar A. Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale Roscoe): a review of recent research. Food and chemical Toxicology, 2008;46:409-420. doi: 10.1016/j.fct.2007.09.085.

Singh O, Khanam Z, Misra N, Srivastava MK. Chamomile (Matricaria chamomilla L.): an overview. Pharmacognosy reviews, 2011 5:82. doi: 10.4103/0973-7847.79103

8Sánchez M, González-Burgos E, Gómez-Serranillos MP. The pharmacology and clinical efficacy of matricaria recutita L.: a systematic review of in vitro, in vivo studies and clin- ical trials. Food Reviews International, 2020; 1-35. doi: 10.1080/87559129.2020.1834577

Sharghi M, Mansurkhani SM, Larky DA Kooti W, Niksefat M, Firoozbakht M, Jouybari,

L. An update and systematic review on the treatment of primary dysmenorrhea. JBRA assisted reproduction, 2019; 23:51. doi: 10.5935/1518-0557.20180083.

Sharifi F, Simbar M, Mojab F, Majd HA. Comparison of the effects of Matricaria cham- omila (Chamomile) extract and mefenamic acid on the intensity of premenstrual syn- drome. Complementary therapies in clinical practice, 2014;20:81-88. doi: 10.1016/j. ctcp.2013.09.002

Saghafi N, Rhkhshandeh H, Pourmoghadam N, Pourali L, Ghazanfarpour M, Beh- rooznia A, Vafisani F. Effectiveness of Matricaria chamomilla (chamomile) extract on pain control of cyclic mastalgia: a double-blind randomised controlled trial. Journal of Obstetrics and Gynaecology, 2018;38:81-84. doi: 10.1080/01443615.2017.1322045

Niazi A, Moradi M. The Effect of Chamomile on Pain and Menstrual Bleeding in Pri- mary Dysmenorrhea: A Systematic Review. International Journal of Community Based Nursing and Midwifery, 2021; 9:174. doi: 10.30476/ijcbnm.2021.87219.1417

Miraj S, Alesaeidi S. A systematic review study of therapeutic effects of Matricaria re- cuitta chamomile (chamomile). Electronic physician, 2016; 8:3024. doi: 10.19082/3024

Sanchez M, Burgos EG, Iglesias I, Gomez-Serranillos MP. Updating the biological inter- est of Valeriana officinalis. Mediterr. Bot, 2021;42: e70280.

Nandhini S, Narayanan KB, Ilango K. Valeriana officinalis: A review of its traditional uses, phytochemistry and pharmacology. Asian J Pharm Clin Res, 2018; 11:36-41 doi. org/10.22159/ajpcr.2018.v11i1. 22588

Moghadam ZB, Rezaei E, Gholami RS, Kheirkhah M, Haghani H. The effect of Valerian root extract on the severity of pre menstrual syndrome symptoms. Journal of traditional and complementary medicine, 2016; 6:309-315. doi: 10.1016/j.jtcme.2015.09.001.

Jenabi E, Shobeiri F, Hazavehei SMM, Roshanaei G. The effect of Valerian on the severity and frequency of hot flashes: a triple-blind randomized clinical trial. Women & health, 2018; 58:297-304. doi: 10.1080/03630242.2017.1296058.

Occhiuto F, Pino A, Palumbo DR, Samperi S, De Pasquale R, Sturlese E, Circosta C. Relaxing effects of Valeriana officinalis extracts on isolated human non-pregnant uter- ine muscle. Journal of Pharmacy and Pharmacology, 2009;61:251-256. doi: 10.1211/ jpp/61.02.0016.

Shahidi S, Bathaei A, Pahlevani P. Antinociceptive effects of Valeriana extract in mice: In- volvement of the dopaminergic and serotonergic systems. Neurophysiology, 2013;45:448- 452.doi. 0090-2977/13/4505-0448

Mahendran G, Rahman LU.Ethnomedicinal, phytochemical and pharmacological up- dates on Peppermint (Mentha× piperita L.) A review. Phytotherapy Research, 2020; 34:2088-2139. doi: 10.1002/ptr.6664.

McKay DL, Blumberg JB. A review of the bioactivity and potential health benefits of chamomile tea (Matricaria recutita L.). Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 2006;20:519-530. doi: 10.1002/ptr.1900.

Beesley A, Hardcastle J, Hardcastle PT, Taylor CJ. Influence of peppermint oil on absorp- tive and secretory processes in rat small intestine. Gut, 1996; 39:214-219. doi: 10.1136/ gut.39.2.214

Kamatou GP, Vermaak I, Viljoen AM, Lawrence BM. Menthol: a simple monoterpene with remarkable biological properties. Phytochemistry, 2013; 96:15-25. doi: 10.1016/j. phytochem.2013.08.005.

Ali SI, Gopalakrishnan B, Venkatesalu V. Pharmacognosy, phytochemistry and pharma- cological properties of Achillea millefolium L.: a review. Phytotherapy Research, 2017; 31:1140-1161. doi.org/10.1002/ptr.5840

Ayoobi F, Shamsizadeh A, Fatemi I, Vakilian A, Allahtavakoli M, Hassanshahi G, Mogh- adam-Ahmadi, A. Bio-effectiveness of the main flavonoids of Achillea millefolium in the pathophysiology of neurodegenerative disorders-a review. Iranian journal of basic medical sciences, 2017;20:604. doi: 10.22038/IJBMS.2017.8827

Yaeesh S, Jamal Q, Khan AU, Gilani AH. Studies on hepatoprotective, antispasmodic and calcium antagonist activities of the aqueous-methanol extract of Achillea millefo- lium. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives, 2006; 20:546-551. doi: 10.1002/ ptr.1897.

Snehlata HS, Payal DR. Fenugreek (Trigonella foenum-graecum L.): an overview. Int J Curr Pharm Rev Res, 2012; 2:169-87.

Nagulapalli Venkata KC, Swaroop A, Bagchi D, Bishayee A. A small plant with big benefits: Fenugreek (Trigonella foenum-graecum Linn.) for disease prevention and health promotion. Molecular nutrition & food research, 2017;61:1600950. doi: 10.1002/ mnfr.201600950.

Yadav UC, Baquer NZ. Pharmacological effects of Trigonella foenum-grae- cum L. in health and disease. Pharmaceutical biology, 2014;52:243-254. doi: 10.3109/13880209.2013.826247.

Olaiya CO, Soetan KO. A review of the health benefits of fenugreek (Trigonella foe- num-graecum L.): Nutritional, Biochemical and pharmaceutical perspectives. Am. J. Soc. Issues Humanit, 2014;4:3-12.

Sreeja S, Anju VS, Sreeja S. In vitro estrogenic activities of fenugreek Trigonella foenum graecum seeds. Indian Journal of Medical Research, 2010;131:814. PMID: 20571172

Steels E, Steele ML, Harold M, Coulson S. Efficacy of a proprietary Trigonella foe- num-graecum L. de-husked seed extract in reducing menopausal symptoms in other- wise healthy women: a double-blind, randomized, placebo-controlled study. Phytother- apy Research, 2017; 31:1316-1322. doi: 10.1002/ptr.5856.

Shamshad Begum S, Jayalakshmi HK, Vidyavathi HG, Gopakumar G, Abin I, Balu M, Krishnakumar IM. A novel extract of fenugreek husk (FenuSMART™) alleviates post- menopausal symptoms and helps to establish the hormonal balance: A randomized, double-blind, placebo-controlled study. Phytotherapy Research, 2016;30:1775-1784. doi: 10.1002/ptr.5680.

Inanmdar W, Sultana A, Mubeen U, Rahman K. Clinical efficacy of Trigonella foe- num graecum (Fenugreek) and dry cupping therapy on intensity of pain in patients with primary dysmenorrhea. Chinese journal of integrative medicine, 2016; 1-8. doi.org/10.1007/s11655-016-2259-x

Anand V, Kumar S, Hedina A. Cinnamomum zeylanicum Linn. The spice with multi potential. Systematic Reviews in Pharmacy, 2016; 7: 24-29.

Wang J, Su B, Jiang H, Cui N, Yu Z, Yang Y, Sun Y. Traditional uses, phytochemistry and pharmacological activities of the genus Cinnamomum (Lauraceae): A review. Fitotera- pia, 2020;146:104675. doi.org/10.1016/j.fitote.2020.104675

Ranasinghe P, Pigera S, Premakumara GA, Galappaththy P, Constantine GR, Katulanda

P. Medicinal properties of ‘true’cinnamon (Cinnamomum zeylanicum): a systematic review. BMC complementary and alternative medicine, 2013;13:1-10.

Jayaprakasha GK, Rao LJM. Chemistry, biogenesis, and biological activities of Cin- namomum zeylanicum. Critical reviews in food science and nutrition, 2011;51547-562. doi: 10.1080/10408391003699550.

Borzoei A, Rafraf M, Niromanesh S, Farzadi L, Narimani F, Doostan F. Effects of cinna- mon supplementation on antioxidant status and serum lipids in women with polycystic ovary syndrome. Journal of traditional and complementary medicine, 2018;8:128-133. doi.org/10.1016/j.jtcme.2017.04.008

Tepe AS, Ozaslan M, Kılıç IH. Traditional uses, phytochemistry, and toxic potential of Teucrium polium L.: A comprehensive review. IJPBP, 2021;1:1-41

Khazaei M, Nematollahi-Mahani SN, Mokhtari T, Sheikhbahaei F. Review on Teucri- um polium biological activities and medical characteristics against different pathologic situations. J Contemp Med Sci, 2018;4:1-6.

Bahramikia S, Yazdanparast R. Phytochemistry and medicinal properties of Teucri- um polium L. (Lamiaceae). Phytotherapy Research, 2012;26:1581-1593. doi: 10.1002/ ptr.4617.

MK, G. N. Antispasmodic effect of Teucrium polium leaf extract on rat ileum. Pajoo- hande, 2007, 12(1): 59-67

Jana S, Shekhawat GS. Anethum graveolens: An Indian traditional medicinal herb and spice. Pharmacognosy reviews, 2010; 4:179. doi: 10.4103/0973-7847.70915

Najaran, Z. T., Hassanzadeh, M. K., Nasery, M., & Emami, S. A. (2016). Dill (Anethum graveolens L.) Oils. In Essential Oils in Food Preservation, Flavor and Safety (pp. 405- 412). Academic Press.

Al-Snafi AE. The pharmacological importance of Anethum graveolens A review. Inter- national Journal of Pharmacy and Pharmaceutical Sciences, 2014;6:11-13.

Chahal KK, Monika AK, Bhardwaj U, Kaur R. Chemistry and biological activities of Anethum graveolens L.(dill) essential oil: A review. Journal of Pharmacognosy and Phy- tochemistry, 2017;6:295-306.

Talebi F, Malchi F, Abedi P, Jahanfar S. Effect of dill (Anethum Graveolens Linn) seed on the duration of labor: A systematic review. Complementary Therapies in Clinical Practice, 2020;41:101251. doi: 10.1016/j.ctcp.2020.101251.

Naseri M, Mojab F, Khodadoost M, Kamalinejad M, Davati A, Choopani R, Emtiazy

M. The study of anti-inflammatory activity of oil-based dill (Anethum graveolens L.) extract used topically in formalin-induced inflammation male rat paw. Iranian journal of pharmaceutical research: IJPR, 2012;11:1169. doi: 10.3233/JRS150697

Sharifi-Rad J, Quispe C, Herrera-Bravo J, Akram M, Abbaass W, Semwal P, Cali- na D. Phytochemical Constituents, Biological Activities, and Health-Promoting Ef- fects of the Melissa officinalis. Oxidative Medicine and Cellular Longevity, 2021. doi. org/10.1155/2021/6584693

Shakeri A, Sahebkar A, Javadi B. Melissa officinalis L.–A review of its traditional uses, phytochemistry and pharmacology. Journal of ethnopharmacology, 2016; 188:204-228. doi: 10.1016/j.jep.2016.05.010.

Moradkhani H, Sargsyan E, Bibak H, Naseri B, Sadat-Hosseini M, Fayazi-Barjin A, Meftahizade H. Melissa officinalis L., a valuable medicine plant: A review. Journal of Medicinal Plants Research, 2010; 4:2753-2759.

Shirazi M, Jalalian MN, Abed M, Ghaemi M. The effectiveness of Melissa officinalis

versus citalopram on quality of life of menopausal women with sleep disorder: a randomized double-blind clinical trial. Revista Brasileira de Ginecologia e Obstetrícia, 2021; 43:126-130. doi: 10.1055/s-0040-1721857.

Akbarzadeh M, Moshfeghy Z, Dehghani M, Emamghoreishi M, Tavakoli P, Zare N. Comparison of the effect of Melissa officinalis capsule and care educational programs on the intensity of physical, mental and social symptoms of premenstrual syndrome in high school female students. Int J Women’s Health Reprod Sci, 2018;16:18-26. doi: 10.17795/nmsjournal27001

Miraj S, Rafieian-Kopaei, Kiani S. Melissa officinalis L: A Review study with an anti- oxidant prospective. Journal of evidence-based complementary & alternative medicine, 2017;22:385-394. doi: 10.1177/2156587216663433.

Bounihi A, Hajjaj G, Alnamer R, Cherrah Y, Zellou A. In vivo potential anti-inflamma- tory activity of Melissa officinalis L. essential oil. Advances in pharmacological sciences, 2013. doi: 10.1155/2013/101759

Pakniat H, Chegini V, Ranjkesh F, Hosseini MA. Comparison of the effect of vi- tamin E, vitamin D and ginger on the severity of primary dysmenorrhea: a sin- gle-blind clinical trial. Obstetrics & gynecology science, 2019;62:462-468. doi: 10.5468/ ogs.2019.62.6.462.

Nasehi M, Sehhatie F, Zamanzadeh V, Delazar A, Javadzadeh Y, Chongheralu BM. Comparison of the effectiveness of combination of fennel extract/vitamin E with ibu- profen on the pain intensity in students with primary dysmenorrhea. Iranian journal of nursing and midwifery research, 2013;18:355.

Sadeghi N, Paknezhad F, Rashidi Nooshabadi M, Kavianpour M, Jafari Rad S, Khadem Haghighian H. Vitamin E and fish oil, separately or in combination, on treatment of primary dysmenorrhea: a double-blind, randomized clinical trial. Gynecological Endo- crinology, 2018;34:804-808. doi: 10.1080/09513590.2018.1450377

Moslemi L, Bekhradi R, Moghaddam G. Comparative effect of fennel extract on the intensity of primary dysmenorrhea. African Journal of pharmacy and Pharmacology, 2012; 6:1770-1773.doi: 10.5897/AJPP12.356

Nayeban S, Jafarnejad F, Nayeban S, Sefidgaran A. A Comparison of the Effects of Vi- tamin E and Vitamin B1 on the Severity and Duration of Pain in Primary Dysmen- orrhea. Journal of Midwifery and Reproductive Health, 2014;2:143-146.doi: 10.22038/ JMRH.2014.2397

Kashanian M, Lakeh MM, Ghasemi A, Noori S. Evaluation of the effect of vitamin E on pelvic pain reduction in women suffering from primary dysmenorrhea. The Journal of reproductive medicine, 2013; 58:34-38.

Lasco A, Catalano A, Benvenga S. Improvement of primary dysmenorrhea caused by a single oral dose of vitamin D: results of a randomized, double-blind, placebo-con- trolled study. Archives of internal medicine, 2012; 172:366-367. doi: 10.1001/archin- ternmed.2011.715.

Moini A, Ebrahimi T, Shirzad N, Hosseini R, Radfar M, Bandarian F, Hemmatabadi

The effect of vitamin D on primary dysmenorrhea with vitamin D deficiency: a randomized double-blind controlled clinical trial. Gynecological Endocrinology, 2016; 32:502-505. doi: 10.3109/09513590.2015.1136617.

Zarei S, Mohammad-Alizadeh-Charandabi S, Mirghafourvand M, Javadzadeh Y, Ef- fati-Daryani F. Effects of calcium-Vitamin D and calcium-alone on pain intensity and menstrual blood loss in women with primary dysmenorrhea: A randomized controlled trial. Pain medicine, 2017;18:3-13. doi: 10.1093/pm/pnw121.

Özel A, Ateş S, Şevket O, Özdemir M, İlhan G, Davutoğlu E. A randomized controlled study of vitamin D in the treatment of primary dysmenorrhea. Duzce Medical Journal, 2019;21:32-36.

Ataee M, Zangeneh M, Mahboubi M. Cholecalciferol for Primary Dysmenorrhea in a College aged Population A Clinical Trial. J Biol Todays World, 2015;4:54-7. doi. org/10.18678/dtfd.480596

Rahnemaei FA, Gholamrezaei A, Afrakhteh M, Zayeri F, Vafa MR, Rashidi A, Ozgoli G. Vitamin D supplementation for primary dysmenorrhea: a double-blind, random- ized, placebo-controlled trial. Obstetrics & Gynecology Science, 2021;64:353-363. doi: 10.5468/ogs.20316

Mallika A, Jayasudha C. A study on the effect of vitamin d supplementation on primary dysmenorrhea: A prospective case control study. 2021; 5(6): 171-174.

Wade C, Wang L, Zhao WJ, Cardini F, Kronenberg F, Gui SQ, Yu J. Acupuncture point injection treatment of primary dysmenorrhoea: a randomised, double blind, controlled study. BMJ open, 2016;6:e008166. doi: 10.1136/bmjopen-2015-008166.

Hosseinlou A, Alinejad V, Alinejad M, Aghakhani N. Effects of fish oil capsules and vitamin B1 tablets on duration and severity of dysmenorrhea in students of high school in Urmia-Iran. Global journal of health science, 2014;6:124. doi: 10.5539/ gjhs.v6n7p124

Mehrpooya M, Eshraghi A, Rabiee S, Larki-Harchegani A, Ataei S. Comparison the effect of fish-oil and calcium supplementation on treatment of primary dysmenorrhea. Reviews on recent clinical trials, 2017;12:148-153. doi: 10.2174/1574887112666170328 125529.

Zafari M, Tofighi M, Aghamohammady A, Behmanesh F, Rakhshaee Z. Comparison of the effect of acupressure, fish oil capsules and ibuprofen on treatment of primary dys- menorrheal. Afr J Pharm Pharmacol, 2011; 5:1115-9. doi: 10.5897/AJPP11.349

Zafari M, Behmanesh F, Mohammadi AA. Comparison of the effect of fish oil and ibuprofen on treatment of severe pain in primary dysmenorrhea. Caspian journal of internal medicine, 2011;2:279.

Rahbar N, Asgharzadeh N, Ghorbani R. Effect of omega-3 fatty acids on intensity of primary dysmenorrhea. International Journal of Gynecology & Obstetrics, 2012; 117:45- 47. doi: 10.1016/j.ijgo.2011.11.019.

Zekavat OR, Karimi MY, Amanat A, Alipour F. A randomised controlled trial of oral zinc sulphate for primary dysmenorrhoea in adolescent females. Australian and New Zealand Journal of Obstetrics and Gynaecology, 2015;55:369-373. doi: 10.1111/ ajo.12367.

Teimoori B, Ghasemi M, Hoseini ZSA, Razavi M. The efficacy of zinc administration in the treatment of primary dysmenorrhea. Oman Medical Journal, 2016;31:107. doi: 10.5001/omj.2016.21

Farrah AM, Halim B, Kaban Y. Effectiveness of zinc supplementation in treating dys- menorrhea. Bali Medical Journal, 2017;6:34-37. doi: 10.15562/bmj.v6i1.380

Kashefi F, Khajehei M, Tabatabaeichehr M, Alavinia M, Asili J. Comparison of the effect of ginger and zinc sulfate on primary dysmenorrhea: a placebo-controlled randomized trial. Pain Management Nursing, 2014;15:826-833. doi: 10.1016/j.pmn.2013.09.001

Rao R, Pai MV. A prospectıve ınterventıonal study for the effect of zınc sulphate on paın severıty and duratıon ın prımary dysmenorrhoea. Indian Obstetrics and Gynae- cology, 2021; 11.

Charandabi SMA, Mirghafourvand M, Nezamivand-Chegini S, Javadzadeh Y. Calcium with and without magnesium for primary dysmenorrhea: a double-blind randomized placebo controlled trial. Int J Women’s Health & Repro Sci, 2017;5:332-8. i 10.15296/ ijwhr.2017.56

Zingg JM. Vitamin E: an overview of major research directions. Molecular aspects of medicine, 2007;28:400-422. doi: 10.1016/j.mam.2007.05.004.

Rizvi S, Raza ST, Faizal Ahmed AA, Abbas S, Mahdi F. The role of vitamin E in human health and some diseases. Sultan Qaboos University Medical Journal, 2014; 14:e157.

Ziaei S, Faghihzadeh S, Sohrabvand F, Lamyian M, Emamgholy T. A randomised place- bo-controlled trial to determine the effect of vitamin E in treatment of primary dysmen- orrhoea. BJOG: An International Journal of Obstetrics & Gynaecology, 2001;108:1181- 1183. doi: 10.1111/j.1471-0528.2003.00279.x.

Doty E, Attaran M. Managing primary dysmenorrhea. Journal of pediatric and adoles- cent gynecology, 2006;19:341-344. doi: 10.1016/j.jpag.2006.06.005.

Wu S, Sun J. Vitamin D, vitamin D receptor, and macroautophagy in inflammation and infection. Discovery medicine, 2011;11:325.

Helde-Frankling M, Björkhem-Bergman L. Vitamin D in pain management. Interna- tional journal of molecular sciences, 2017;18:2170. doi: 10.3390/ijms18102170.

Vermeer CV. (2012). Vitamin K: the effect on health beyond coagulation–an overview.

Food & nutrition research, 2012;56:5329. doi: 10.3402/fnr.v56i0.5329.

Simes DC, Viegas CS, Araújo N, Marreiros C. Vitamin K as a diet supplement with im- pact in human health: current evidence in age-related diseases. Nutrients, 2020;12:138. doi: 10.3390/nu12010138.

Gröber U, Reichrath J, Holick MF, Kisters K. Vitamin K: an old vitamin in a new per- spective. Dermato-endocrinology, 2014;6: e968490. doi: 10.4161/19381972.2014.968490

Martel JL, Kerndt CC, Doshi H, Franklin DS. Vitamin B1 (thiamine). In StatPearls [Internet]. StatPearls Publishing 2021.

Lonsdale D. Thiamin. Advances in food and nutrition research, 2018;83:1-56. doi: 10.1016/bs.afnr.2017.11.001.

Martin PR. Molecular mechanisms of thiamine utilization. Current molecular medi- cine, 2001; 1:197-207. doi: 10.2174/1566524013363870.

Samieipour S, Kiani F, Babaei Heydarabadi A, Tavassoli E. Comparing the effects of vitamin B1 and calcium on premenstrual syndrome (PMS) among female students, Ilam-Iran. International Journal of Pediatrics, 2016;4:3519-3528. doi: 10.22038/ ijp.2016.7345

Mori TA, Beilin LJ. Omega-3 fatty acids and inflammation. Current atherosclerosis re- ports, 2004;6:461-467. doi: 10.1007/s11883-004-0087-5.

Calder PC. Omega-3 fatty acids and inflammatory processes: from molecules to man.

Biochemical Society Transactions, 2017;45:1105-1115. doi: 10.1042/BST20160474.

Saldeen P, Saldeen T. Women and omega-3 Fatty acids. Obstetrical & gynecological sur- vey, 2004;59:722-730. doi: 10.1097/01.ogx.0000140038.70473.96.

Harel Z, Biro FM, Kottenhahn RK, Rosenthal SL. Supplementation with omega-3 poly- unsaturated fatty acids in the management of dysmenorrhea in adolescents. Ameri- can journal of obstetrics and gynecology, 1996;174:1335-1338. doi: 10.1016/s0002- 9378(96)70681-6.

Plum L. M, Rink L, Haase H. The essential toxin: impact of zinc on human health. In- ternational journal of environmental research and public health, 2010;7:1342-1365. doi: 10.3390/ijerph7041342.

Bhowmik D, Chiranjib K, Kumar S. A potential medicinal importance of zinc in human health and chronic. Int J Pharm, 2010; 1:05-11.

Swaim RA, Barner JC, Brown CM. The relationship of calcium intake and exercise to osteoporosis health beliefs in postmenopausal women. Research in Social and Adminis- trative Pharmacy, 2008; 4:153-163. doi: 10.1016/j.sapharm.2007.03.004.

Thys-Jacobs S. Micronutrients and the premenstrual syndrome: the case for calcium. Journal of the American College of Nutrition, 2000;19:220-227. doi: 10.1080/07315724.2000.10718920.

Penland JG, Johnson PE. Dietary calcium and manganese effects on menstrual cycle symptoms. American journal of obstetrics and gynecology, 1993; 168:1417-1423. doi: 10.1016/s0002-9378(11)90775-3.

Langley WF, Mann D. Central nervous system magnesium deficiency. Archives of in- ternal medicine, 1991;151: 593-596.

Parazzini F, Di Martino M, Pellegrino P. Magnesium in the gynecological practice: a literature review. Magnesium research, 2017;30:1-7. doi: 10.1684/mrh.2017.0419.

Castiglioni S, Cazzaniga A, Albisetti W, Maier JA. Magnesium and osteoporosis: cur- rent state of knowledge and future research directions. Nutrients, 2013;5:3022-2033. doi: 10.3390/nu5083022